These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 19247716
1. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Li L, Jiang AC, Dong P, Wang H, Xu W, Xu C. Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716 [Abstract] [Full Text] [Related]
2. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K. Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [Abstract] [Full Text] [Related]
3. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC. Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145 [Abstract] [Full Text] [Related]
4. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH. Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169 [Abstract] [Full Text] [Related]
5. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Ye X, Liu T, Gong Y, Zheng B, Meng W, Leng Y. Leuk Res; 2009 Aug 21; 33(8):1114-9. PubMed ID: 19036441 [Abstract] [Full Text] [Related]
6. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line. Bhat UG, Winter MA, Pearce HL, Beck WT. Mol Pharmacol; 1995 Oct 21; 48(4):682-9. PubMed ID: 7476894 [Abstract] [Full Text] [Related]
7. Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids. Xing H, Wang S, Weng D, Chen G, Yang X, Zhou J, Xu G, Lu Y, Ma D. Oncol Rep; 2007 Jan 21; 17(1):117-22. PubMed ID: 17143487 [Abstract] [Full Text] [Related]
8. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B. Pharmazie; 2008 Jul 21; 63(7):528-33. PubMed ID: 18717489 [Abstract] [Full Text] [Related]
9. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference. Stege A, Priebsch A, Nieth C, Lage H. Cancer Gene Ther; 2004 Nov 21; 11(11):699-706. PubMed ID: 15375376 [Abstract] [Full Text] [Related]
10. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Li B, Ye T, Zhao L, Li DH, Gou XH, Zhao LY, Han L, Chen L, Yan LN, Gong JP. Hepatobiliary Pancreat Dis Int; 2006 Nov 21; 5(4):552-9. PubMed ID: 17085341 [Abstract] [Full Text] [Related]
11. [Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/ Taxol) and explore its underlying mechanism]. Liu Q, Liu XJ, Chen YJ, Wang J. Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May 21; 42(3):326-30, 357. PubMed ID: 21826992 [Abstract] [Full Text] [Related]
12. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, Piao SL, Du ZW, Gao S, Zheng DM. Chin Med J (Engl); 2005 Jun 05; 118(11):893-902. PubMed ID: 15978189 [Abstract] [Full Text] [Related]
13. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB. He Y, Zhang J, Zhang J, Yuan Y. Chin Med J (Engl); 2000 Sep 05; 113(9):848-51. PubMed ID: 11776085 [Abstract] [Full Text] [Related]
14. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein. Huang L, Wang C, Zheng W, Liu R, Yang J, Tang C. Anticancer Drugs; 2007 Oct 05; 18(9):1075-80. PubMed ID: 17704658 [Abstract] [Full Text] [Related]
15. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Mechetner E, Kyshtoobayeva A, Zonis S, Kim H, Stroup R, Garcia R, Parker RJ, Fruehauf JP. Clin Cancer Res; 1998 Feb 05; 4(2):389-98. PubMed ID: 9516927 [Abstract] [Full Text] [Related]
16. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells. Chen F, Wang T, Wang J, Wang ZQ, Qian M. Acta Pharmacol Sin; 2008 Apr 05; 29(4):458-64. PubMed ID: 18358092 [Abstract] [Full Text] [Related]
17. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, Wang Z. Gynecol Oncol; 2010 Oct 05; 119(1):125-30. PubMed ID: 20624637 [Abstract] [Full Text] [Related]
18. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines. Takeda M, Mizokami A, Mamiya K, Li YQ, Zhang J, Keller ET, Namiki M. Prostate; 2007 Jun 15; 67(9):955-67. PubMed ID: 17440963 [Abstract] [Full Text] [Related]
19. Clinical relationship between MDR1 gene and gallbladder cancer. Wang BL, Zhai HY, Chen BY, Zhai SP, Yang HY, Chen XP, Zhao WT, Meng L. Hepatobiliary Pancreat Dis Int; 2004 May 15; 3(2):296-9. PubMed ID: 15138130 [Abstract] [Full Text] [Related]
20. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells. Brouillard F, Tondelier D, Edelman A, Baudouin-Legros M. Cancer Res; 2001 Feb 15; 61(4):1693-8. PubMed ID: 11245485 [Abstract] [Full Text] [Related] Page: [Next] [New Search]